Status:
COMPLETED
Effectiveness of Hydrolyzed Collagen Peptide Injection for the Treatment of Collateral Ligament Pain
Lead Sponsor:
Tiss'You srl
Conditions:
Collateral Ligament Injury of Stifle Joint
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Conducted by Binh Luu Thi, Lan Tran Thi, and Minh Hang Hoang Thi at Thai Nguyen National Hospital, the study investigates a new approach to treating persistent collateral ligament pain, common among a...
Eligibility Criteria
Inclusion
- age above 18 years,
- lateral knee pain with a duration of 3 months or longer,
- ultrasound evidence of inflammation of the femoral condyle attachment point,
- agreement to participate in the study
Exclusion
- trauma,
- infection,
- dermatitis at the site of the inflammation,
- damage to surrounding knee structures,
- history of chronic inflammatory arthritis (such as gout or rheumatoid arthritis),
- local corticosteroid injection within 3 months before participating in the study.
Key Trial Info
Start Date :
April 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 4 2023
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT05971004
Start Date
April 13 2022
End Date
April 4 2023
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tiss'You
Domagnano, RSM, San Marino, 47895